Kaiku Health, the developer of digital health intervention platform in oncology, adds medical expertise and years of experience in oncology and hematology with Dr. Mari Metso-Lintula joining the team as Medical Director.
Dr. Metso-Lintula is an experienced oncologist and hematologist with a background in the medical device industry and electronic patient-reported outcomes. Her responsibilities at Kaiku Health will include clinical and research cooperation with cancer centers, research institutes and life science companies.
“Medical expertise, specifically expertise in oncology, is a key factor within Kaiku Health due to the nature of our product – a medical device for supporting cancer care. Our product relies on proven clinical data. With Mari joining us, our ability to further produce this clinical data as well as implementing clinical knowledge into the product is improved. Mari’s background and versatile skill set makes her a great addition to our team!” , Vesa Kataja, Chief Medical Officer at Kaiku Health.
About Kaiku Health
Kaiku Health is a digital health intervention platform classified as a Medical Device in cancer care. Its algorithms screen symptoms, notify the care team and provide personalised support for patients. Kaiku Health has modules for over 25 cancer types across different cancer care pathways and is currently in use in leading European cancer clinics and hospitals. Kaiku Health is a part of Elekta.